Literature DB >> 7387817

Naloxone pharmacokinetics in the newborn.

T A Moreland, J E Brice, C H Walker, A C Parija.   

Abstract

1 Plasma naloxone levels were determined by RIA over a period of 6--36 h in three groups of neonates, (1) those given 35 microgram i.v. (n = 6), (2) those given 70 microgram i.v. (n = 6) and (3) those given 200 microgram i.m. (n = 17) naloxone HCl within 1 min of birth. 2 After intravenous administration of 35 and 70 microgram of naloxone peak levels of 4--15 ng/ml and 9--20 ng/ml respectively were reached in 5--40 min and the mean plasma half-life after both doses was 3.1 +/- 0.5 h. 3 Peak levels of 7--35 ng/ml were reached 0.5 to 2 h after intramuscular administration of 200 microgram. The fall in concentration after this was consistently biphasic with the levels declining rapidly between one and four hours and then slowly from four hours onwards. 4 Plasma levels at 24--36 h after i.m. administration were as high as they were 4 h after i.v. administration of 35 microgram and this may account for the prolonged duration of action when this route is used.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7387817      PMCID: PMC1430011          DOI: 10.1111/j.1365-2125.1980.tb01088.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  15 in total

1.  Bioavailability and single-dose pharmacokinetics of intramuscular phenytoin.

Authors:  H B Kostenbauder; R P Rapp; J P McGovren; T S Foster; D G Perrier; H M Blacker; W C Hulon; A W Kinkel
Journal:  Clin Pharmacol Ther       Date:  1975-10       Impact factor: 6.875

2.  Abortion and distribution of naloxone in rats after oral and intravenous administration.

Authors:  S H Weinstein; M Pfeffer; J M Schor; L Franklin; M Mintz; E R Tutko
Journal:  J Pharm Sci       Date:  1973-09       Impact factor: 3.534

3.  Metabolites of naloxone in human urine.

Authors:  S H Weinstein; M Pfeffer; J M Schor; L Indindoli; M Mintz
Journal:  J Pharm Sci       Date:  1971-10       Impact factor: 3.534

4.  Isolation of naloxone-3-glucuronide from human urine.

Authors:  J M Fujimoto
Journal:  Proc Soc Exp Biol Med       Date:  1970-01

5.  Isolation of two different glucuronide metabolites of naloxone from the urine of rabbit and chicken.

Authors:  J M Fujimoto
Journal:  J Pharmacol Exp Ther       Date:  1969-07       Impact factor: 4.030

Review 6.  Clincial pharmacokinetics in neonates.

Authors:  P L Morselli
Journal:  Clin Pharmacokinet       Date:  1976       Impact factor: 6.447

7.  Pharmacokinetics of naloxone in rats and in man: basis for its potency and short duration of action.

Authors:  S H Ngai; B A Berkowitz; J C Yang; J Hempstead; S Spector
Journal:  Anesthesiology       Date:  1976-05       Impact factor: 7.892

8.  Use of nalotone to to reverse narcotic respiratory depression in the newborn infant.

Authors:  T Gerhardt; E Bancalari; H Cohen; L F Rocha
Journal:  J Pediatr       Date:  1977-06       Impact factor: 4.406

9.  Metabolic reduction of naltrexone. I. Synthesis, separation and characterization of naloxone and naltrexone reduction products and qualitative assay of urine and bile following administration of naltrexone, alpha-naltrexol, or beta-naltrexol.

Authors:  L Malspeis; M S Bathala; T M Ludden; H B Bhat; S G Frank; T D Sokoloski; B E Morrison; R H Reuning
Journal:  Res Commun Chem Pathol Pharmacol       Date:  1975-09

10.  Reversal of narcotic depression in the neonate by nalozone.

Authors:  J M Evans; M I Hogg; M Rosen
Journal:  Br Med J       Date:  1976-11-06
View more
  4 in total

Review 1.  Glucuronidation in humans. Pharmacogenetic and developmental aspects.

Authors:  S N de Wildt; G L Kearns; J S Leeder; J N van den Anker
Journal:  Clin Pharmacokinet       Date:  1999-06       Impact factor: 6.447

2.  Therapeutic monitoring of nalbuphine: transplacental transfer and estimated pharmacokinetics in the neonate.

Authors:  E Nicolle; P Devillier; B Delanoy; C Durand; G Bessard
Journal:  Eur J Clin Pharmacol       Date:  1996       Impact factor: 2.953

3.  Naloxone and Metabolites Quantification in Cord Blood of Prenatally Exposed Newborns and Correlations with Maternal Concentrations.

Authors:  Samantha L Wiegand; Madeleine J Swortwood; Marilyn A Huestis; John Thorp; Hendreé E Jones; Neeta L Vora
Journal:  AJP Rep       Date:  2016-10

Review 4.  [Newborn resuscitation and support of transition of infants at birth].

Authors:  John Madar; Charles C Roehr; Sean Ainsworth; Hege Ersda; Colin Morley; Mario Rüdiger; Christiane Skåre; Tomasz Szczapa; Arjan Te Pas; Daniele Trevisanuto; Berndt Urlesberger; Dominic Wilkinson; Jonathan P Wyllie
Journal:  Notf Rett Med       Date:  2021-06-02       Impact factor: 0.892

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.